NEW YORK (GenomeWeb) – Natera reported after the close of the market on Wednesday that its second quarter 2018 revenues rose 21 percent year over year.
The San Carlos, California-based molecular diagnostics firm reported total Q2 2018 revenues of $63.1 million, compared to $52.3 million in Q2 2017, beating analysts' average estimate of $61.2 million.